Stock screenerAll disclosures →
EDGAR →
HRMY
Conviction 75HealthcareScan · Thu, Jun 25, 2026HRMY$34.15-0.87%
ResistanceSupportVol 14Vol MA14 829.47K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price34.15
Change-0.87%
Gap+0.49%
Rel volume1.66×
Avg volume857.99K
Avg $ vol28.66M
SMA 2033.30
SMA 5031.85
SMA 20032.25
Price vs 50+7.21%
Price vs 200+5.91%
MA stackmixed
50/200 cross—
Supertrendup · 31.84
RSI (14)59
MACD hist-0.03
MACD crossbear · 3d
Stoch %K / %D54 / 61
ADX (14)20
+DI / −DI28 / 20
RSI divergence—
MACD divergence—
ATR %+3.12%
ADR %3.14%
52w high40.51
52w low25.90
From 52w high-15.70%
Above 52w low+31.85%
New 52w highNo
SqueezeOff
Bollinger width15.23%
%B0.67
Donchian pos66.07%
Donchian high35.95
Donchian low30.65
AVWAP (52w high)32.08
vs AVWAP high+6.47%
AVWAP (52w low)32.27
vs AVWAP low+5.82%
OBV trendUp
Chaikin MF (20)0.05
Today vs 20d1.66×
Avg vol (14d)829.47K
Avg vol (20d)857.99K
Avg $ vol (20d)28.66M
Market cap1.98B
RS 3m (vs SPY)+14.86%
RS 6m (vs SPY)-16.62%
RS line new highNo
Trend template6/8
Technical rank59.3
1 week+1.13%
1 month+13.49%
3 months+23.78%
6 months-12.12%
1 year+6.52%
YTD-8.64%
P/E12.46
P/B2.17
P/S2.28
P/FCF5.68
EPS2.71
Div yield—
ROE17.43%
ROA12.48%
Debt/Eq0.17
Current3.58
EV/EBITDA—
Gross margin77.16%
Net margin18.27%
Rev growth21.51%
EPS growth9.07%
Price target49.50
Target upside44.95%
Analyst ratingBuy
Institutional105.52%
Ent. value1.55B
Revenue215.39M
Net income32.49M
Gross profit170.88M
Free cash flow347.89M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out57.89M
Employees293
ListedWed, Aug 19, 2020
Free float47.26M
Float %82.1%
Short interest5.94M
Days to cover8.6d
Short volume74.8%
Squeeze score80 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast$0.87 · 4 est
Last EPS vs est$0.55 vs $0.76
Last surprise-27.6% miss
Setup gradeA
Conviction75 / 100
Pattern quality—
Tech rank59.3 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance34.48
Support29.07
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in HRMY
No recent disclosed trades by Congress in HRMY. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in HRMY · 8 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Graf R. Mark Director · Stock Option · 2026-05-14 | Grant | 21.87K | $0 | 2026-05-14 | 2026-05-18 |
Germano Geno J Director · Stock Option · 2026-05-14 | Grant | 21.23K | $0 | 2026-05-14 | 2026-05-18 |
Szyper Linda M Director · Stock Option · 2026-05-14 | Grant | 21.87K | $0 | 2026-05-14 | 2026-05-18 |
Philip Ron M Director · Stock Option · 2026-05-14 | Grant | 21.87K | $0 | 2026-05-14 | 2026-05-18 |
Sender Gary Director · Stock Option · 2026-05-14 | Grant | 21.87K | $0 | 2026-05-14 | 2026-05-18 |
Sabater Juan A. Director · Stock Option · 2026-05-14 | Grant | 21.87K | $0 | 2026-05-14 | 2026-05-18 |
Budur Kumar CHIEF MEDICAL OFFICER · Restricted Stock Units · 2026-05-01 | Exercise | 18.75K | $0 | 2026-05-01 | 2026-05-18 |
Budur Kumar CHIEF MEDICAL OFFICER · Common Stock · 2026-05-01 | Exercise | 18.75K | $0 | 2026-05-01 | 2026-05-18 |
Budur Kumar CHIEF MEDICAL OFFICER · Common Stock · 2026-05-01 | Tax | 8.88K | $283K | 2026-05-01 | 2026-05-18 |
Reicin Glenn CHIEF FINANCIAL OFFICER · Stock Option · 2026-04-14 | Grant | 164.31K | $0 | 2026-04-14 | 2026-05-18 |
SEC filings
EDGAR filings in HRMY · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.